Biomarkers in Trypanosoma cruzi-infected and uninfected individuals with varying severity of cardiomyopathy in Santa Cruz, Bolivia.

• Main Authors: Emi E Okamoto (Author), Jacqueline E Sherbuk (Author), Eva H Clark (Author), Morgan A Marks (Author), Omar Gandarilla (Author), Gerson Galdos-Cardenas (Author), Angel Vasquez-Villar (Author), Jeong Choi (Author), Thomas C Crawford (Author), Rose Q Do (Author), Antonio B Fernandez (Author), Rony Colanzi (Author), Jorge Luis Flores-Franco (Author), Robert H Gilman (Author), Caryn Bern (Author), Chagas Disease Working Group in Bolivia and Peru (Author)
• Format: Book
• Published: Public Library of Science (PLoS), 2014-10-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Twenty to thirty percent of persons with Trypanosoma cruzi infection eventually develop cardiomyopathy. If an early indicator were to be identified and validated in longitudinal studies, this could enable treatment to be prioritized for those at highest risk. We evaluated cardiac and extracellular m...